Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
NCT Number: NCT06196164
The purpose of this study is to evaluate the efficacy and safety of EUS-BD compared with ERCP-BD in low biliary obstruction caused by periampullary cancer, pancreatic cancer or low bile duct cancer. This is a single center, prospective, randomized-controlled study. The primary endpoint of this study is stent patency time, and secondary endpoints include technical success rate, clinical success rate, operation time, operation related complications rate, reintervention rate, stent patency rate at 6 months, and 1-year postoperative survival rate.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Beijing, Beijing Municipality, 100730, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
We observe the bile duct through endoscopic ultrasound, then puncture through the gastric or duodenum wall and place a guide wire, expanding along the guide wire, finally place a stent between the bile duct and the stomach or intestine for drainage.
We use a Duodenoscopy to pass through mouth down to the small opening where the bile duct and pancreatic drain. A small narrow catheter is passed through the scope to gain access to the drainage duct , followed by advancement of a wire deep into the duct. A small cut is made at the bile duct opening to help facilitate a stent placed in the bile duct.
Time frame: 0-24months
The interval between the operation day and the occurrence of cholangitis and biliary obstruction
Peking Union Medical College Hospital
Other
A Randomized Controlled Trial of Malignancy Low Biliary Tract Obstruction Drainage Strategies
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06197984
Bile Duct Diseases, Biliary Tract Diseases
Timișoara, Romania
View Trial DetailsNCT06948279
Bile Duct Diseases, Biliary Tract Diseases
Shebeen El-Kom, Monufia Governorate, Egypt
View Trial DetailsNCT04251013
Biliary Stricture, Hyperbilirubinemia
Charenton-le-Pont, France
View Trial DetailsNCT04582240
Bile Duct Injury, Biliary Disease
View Trial Details